- Home
- CRVS vs MMD Comparison
CRVS vs MMD Comparison
Compare CRVS & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- MMD
- Stock Information
- Founded
- CRVS 2014
- MMD 2012
- Country
- CRVS United States
- MMD United States
- Employees
- CRVS N/A
- MMD N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- MMD Investment Managers
- Sector
- CRVS Health Care
- MMD Finance
- Exchange
- CRVS Nasdaq
- MMD Nasdaq
- Market Cap
- CRVS 305.4M
- MMD 268.0M
- IPO Year
- CRVS 2016
- MMD N/A
- Fundamental
- Price
- CRVS $4.11
- MMD $14.76
- Analyst Decision
- CRVS Strong Buy
- MMD
- Analyst Count
- CRVS 4
- MMD 0
- Target Price
- CRVS $15.00
- MMD N/A
- AVG Volume (30 Days)
- CRVS 1.2M
- MMD 74.7K
- Earning Date
- CRVS 08-05-2025
- MMD 01-01-0001
- Dividend Yield
- CRVS N/A
- MMD 4.88%
- EPS Growth
- CRVS N/A
- MMD N/A
- EPS
- CRVS N/A
- MMD N/A
- Revenue
- CRVS N/A
- MMD N/A
- Revenue This Year
- CRVS N/A
- MMD N/A
- Revenue Next Year
- CRVS N/A
- MMD N/A
- P/E Ratio
- CRVS N/A
- MMD N/A
- Revenue Growth
- CRVS N/A
- MMD N/A
- 52 Week Low
- CRVS $1.78
- MMD $14.30
- 52 Week High
- CRVS $10.00
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- CRVS 53.94
- MMD 57.66
- Support Level
- CRVS $3.79
- MMD $14.70
- Resistance Level
- CRVS $4.31
- MMD $14.86
- Average True Range (ATR)
- CRVS 0.29
- MMD 0.13
- MACD
- CRVS 0.00
- MMD 0.01
- Stochastic Oscillator
- CRVS 72.64
- MMD 63.80
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
MainStay MacKay DefinedTerm Municipal Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.